Stay updated on Texture Analysis Predicts Pembrolizumab Response in Melanoma: Clinical Trial
Sign up to get notified when there's something new on the Texture Analysis Predicts Pembrolizumab Response in Melanoma: Clinical Trial page.

Latest updates to the Texture Analysis Predicts Pembrolizumab Response in Melanoma: Clinical Trial page
- CheckyesterdayChange DetectedStudy status updated to Terminated with enrollment closed due to slow accrual; primary outcome analysis was not performed.SummaryDifference0.5%

 - Check8 days agoNo Change Detected
 - Check30 days agoChange DetectedAdded a government-status notice and updated version to v3.2.0; removed the old v3.1.0 tag. The page now communicates current operating status and a new version release.SummaryDifference4%

 - Check37 days agoChange DetectedUpdated the page revision from v3.0.2 to v3.1.0, indicating a new software release or document update. No changes to core content, pricing, or stock are evident.SummaryDifference0.1%

 - Check51 days agoChange DetectedThe page now shows Revision: v3.0.2, replacing v3.0.1. The 'Back to Top' link was removed as part of a minor UI cleanup.SummaryDifference0.2%

 - Check59 days agoChange DetectedThe web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.2%

 - Check66 days agoChange DetectedThe web page has added a facility name, location, and specific medical topics related to skin and connective tissue diseases, while removing various location details and several medical resources and topics.SummaryDifference3%

 
Stay in the know with updates to Texture Analysis Predicts Pembrolizumab Response in Melanoma: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Texture Analysis Predicts Pembrolizumab Response in Melanoma: Clinical Trial page.